STRUCTURAL REQUIREMENTS FOR BIOACTIVATION OF ANTICONVULSANTS TO CYTO-TOXIC METABOLITES INVITRO

被引：28

作者：

RILEY, RJ ^{[1
]}

KITTERINGHAM, NR ^{[1
]}

PARK, BK ^{[1
]}

机构：

[1] UNIV LIVERPOOL,DEPT PHARMACOL & THERAPEUT,POB 147,LIVERPOOL L69 3BX,ENGLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 28卷 / 04期

关键词：

D O I：

10.1111/j.1365-2125.1989.tb03530.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：482 / 487

页数：6

共 23 条

[1]

BOYUM A, 1984, METHOD ENZYMOL, V108, P88

[2]

CHOW SA, 1982, DRUG METAB DISPOS, V10, P156

[3] IMINOSTILBENE - METABOLITE OF CARBAMAZEPINE ISOLATED FROM RAT URINE [J].

CSETENYI, J ;

BAKER, KM ;

FRIGERIO, A ;

MORSELLI, PL .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (04) :340-341

[4]

GERSON WT, 1983, BLOOD, V61, P889

[5]

GROSSMAN SJ, 1988, J PHARMACOL EXP THER, V244, P118

[6] ENZYMATIC ACTIVATION OF CHEMICALS TO TOXIC METABOLITES [J].

GUENGERICH, FP ;

LIEBLER, DC .

CRC CRITICAL REVIEWS IN TOXICOLOGY, 1985, 14 (03) :259-307

[7] SPECIES-DIFFERENCES IN THE CYTO-TOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-OH-2-ACETYLAMINOFLUORENE [J].

HOLME, JA ;

SODERLUND, EJ .

CARCINOGENESIS, 1985, 6 (03) :421-425

[8] PHARMACOLOGICAL INHIBITION OF ALDOSE REDUCTASE IN HUMAN DIABETIC NEUROPATHY [J].

JASPAN, J .

DRUGS, 1986, 32 :23-29

[9] ARENE OXIDES - NEW ASPECT OF DRUG-METABOLISM [J].

JERINA, DM ;

DALY, JW .

SCIENCE, 1974, 185 (4151) :573-582

[10]

LERTRATANANGKOON K, 1982, DRUG METAB DISPOS, V10, P1

← 1 2 3 →